CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Two new studies in the May 29 issue of The New England Journal of Medicine add to the growing evidence that Fuzeon is effective in treating HIV in patients resistant to other antiretroviral drugs, with new data showing the drug doubles the chances for someone with drug resistance to achieve an undetectable viral load. In one of the studies, researchers studied 1,000 patients from 48 cities in the United States, Canada, Mexico, and Brazil who had at least six months of treatment with other anti-HIV drugs and had developed resistance to one or more of the medications. The study concluded that adding Fuzeon to an existing drug cocktail "provided significant antiretroviral and immunologic benefit " for the study participants. A second study, conducted in the United States, Australia, and Europe, also showed Fuzeon to significantly boost the effectiveness of antiretroviral therapy for those already treated with other anti-HIV medications. In an accompanying editorial, Karen Tashima and Charles Carpenter of Miriam Hospital in Providence, R.I., write that the studies offer "heartening news of the success" of Fuzeon because the two research projects provided nearly identical results. But they add that additional issues still need to be worked out, including the high pricing of the medication--Fuzeon is priced at nearly $20,000 for a one-year regimen--and concerns about adverse side effects of the drug. The European Union on Tuesday gave marketing approval to drugmakers Roche and Trimeris to sell Fuzeon in all 15 member nations. The U.S. Food and Drug Administration approved Fuzeon for sale on March 13. Fuzeon, previously known as T-20, is the world's first HIV fusion inhibitor that works outside immune system cells to prevent HIV from attaching to and infecting the cells. All other available anti-HIV medications work to slow HIV replication inside cells already infected with the virus.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
21+ steamy photos of Scotland’s finest gay men in Elska Glasgow
February 01 2024 10:07 PM
More Than 50 of Our Favorite LGBTQ+ Moms
May 12 2024 11:44 AM
Conjoined twins Lori Schappell and trans man George Schappell dead at 62
April 27 2024 6:13 PM
Latest Stories
Joe Biden sends queer lawmakers & LGBTQ+ allies to Paris Olympics
July 24 2024 12:08 PM
Kamala Harris rides wave of Democratic energy at kickoff event in Wisconsin
July 23 2024 3:36 PM
'Devastated:' A six-week abortion ban will go into effect in Iowa next week
July 23 2024 2:28 PM
Four hours, 44,000 Black women, and one Zoom call
July 23 2024 2:17 PM
Record 1.2 million people show out for Cologne’s Pride parade
July 23 2024 10:51 AM